Behavioral Neuroscience – News and Features

Researchers mapped changes in the brain’s architecture before, during and after propofol sedation, guided by functional magnetic resonance imaging, enabling them to monitor blood flow to areas of the brain during the (un)conscious state.

Rapid changes in brain activity have been linked to the experience of cravings, providing a better understanding of how brain activity shifts over time and how it might go awry in neurological disorders.

Cognitive behavioral therapy leads to adaptive changes in brain circuitry in just two months, relieving depression and predicting which patients benefit from long-term therapy.

Pesticide residues in food are a growing concern for consumers, regulators and the agricultural industry alike. This article will discuss current issues in pesticide analysis of food and the analytical solutions that are helping to address them.

A study found that individuals with depression have a brain network, the frontostriatal salience network, nearly twice as large as those without depression. This enlargement is stable over time and could serve as a biomarker for early diagnosis.

A UK study has identified three pioneer bacteria in newborns’ guts, with two beneficial for breast milk digestion and pathogen defense. These findings suggest potential for creating personalized probiotics tailored to infant microbiomes.

Research has found a correlation between nighttime light pollution and increased prevalence of Alzheimer's disease. In the US, younger individuals exposed to high nighttime light intensity show a stronger association with Alzheimer’s than other risk.

A new study has revealed that mindfulness meditation engages distinct brain mechanisms to reduce pain.

Study participants who had experienced a sports-related concussion had better cognitive performance in some areas than those who had never suffered a concussion, pointing to the potential protective effects of sports participation.

A study analyzed data from 300,000 adults and found no evidence linking GLP-1 analogues to increased suicide, self-harm, or depression. The findings support the European Medicines Agency's conclusion.